BR0108500A - Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase - Google Patents

Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase

Info

Publication number
BR0108500A
BR0108500A BR0108500-0A BR0108500A BR0108500A BR 0108500 A BR0108500 A BR 0108500A BR 0108500 A BR0108500 A BR 0108500A BR 0108500 A BR0108500 A BR 0108500A
Authority
BR
Brazil
Prior art keywords
arylpiperidines
arylpiperazines
metalloproteinase inhibitors
inhibitors
metalloproteinase
Prior art date
Application number
BR0108500-0A
Other languages
English (en)
Inventor
Bernard Christophe Barlaam
Robert Ian Dowell
Nicholas John Newcombe
Howard Tucker
David Waterson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0108500A publication Critical patent/BR0108500A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

"ARILPIPERAZINAS E ARILPIPERIDINAS E SEU USO COMO AGENTES INIBIDORES DE METALOPROTEINASE". A presente invenção se refere a compostos de fórmula (i), de utilidade como inibidores de metaloproteinase, especialmente como inibidores da MPP13.
BR0108500-0A 2000-02-21 2001-02-15 Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase BR0108500A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00400469 2000-02-21
PCT/GB2001/000616 WO2001062751A1 (en) 2000-02-21 2001-02-15 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents

Publications (1)

Publication Number Publication Date
BR0108500A true BR0108500A (pt) 2003-04-29

Family

ID=8173566

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108500-0A BR0108500A (pt) 2000-02-21 2001-02-15 Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase

Country Status (13)

Country Link
US (1) US20030139419A1 (pt)
EP (1) EP1261595A1 (pt)
JP (1) JP2003524008A (pt)
KR (1) KR20020079882A (pt)
CN (1) CN1404474A (pt)
AU (1) AU3385401A (pt)
BR (1) BR0108500A (pt)
CA (1) CA2396971A1 (pt)
IL (1) IL150882A0 (pt)
MX (1) MXPA02008112A (pt)
NO (1) NO20023951L (pt)
WO (1) WO2001062751A1 (pt)
ZA (1) ZA200205845B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119473D0 (en) * 2001-08-09 2001-10-03 Astrazeneca Compounds
GB0119474D0 (en) * 2001-08-09 2001-10-03 Astrazeneca Ab Compounds
GB0119472D0 (en) * 2001-08-09 2001-10-03 Astrazeneca Ab Compounds
AU2003229883B2 (en) 2002-04-03 2009-06-11 Topotarget Uk Limited Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2513246A1 (en) 2003-01-17 2004-08-05 Topotarget Uk Limited Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors
WO2004078751A1 (ja) 2003-03-07 2004-09-16 Kowa Co., Ltd. ベンゾフラン誘導体
JP2006527754A (ja) * 2003-06-19 2006-12-07 セルテック アール アンド ディ リミテッド Ｃｄ２３分断阻害物質としてのヒドロキサム酸スルホンアミド
US20060241118A1 (en) * 2004-06-18 2006-10-26 Celltech R&D Limited Hydroxamate sulfonamides as cd23 shedding inhibitors
KR100838645B1 (ko) * 2006-09-28 2008-06-16 한국화학연구원 베타-세크리테아제 활성을 억제하는 피페리딘 화합물
CA3115038A1 (en) 2018-10-04 2020-04-09 Inserm (Institut National De La Sante Et De La Recherche Medicale) Egfr inhibitors for treating keratodermas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000029858A (ko) * 1996-08-07 2000-05-25 마르크 젠너 엠엠피와티엔에프억제활성을갖는히드록삼산및카르복실산유도체
WO1998016514A1 (en) * 1996-10-16 1998-04-23 American Cyanamid Company Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
GB9725782D0 (en) * 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
EP1107953A1 (en) * 1998-08-29 2001-06-20 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds

Also Published As

Publication number Publication date
ZA200205845B (en) 2003-10-22
WO2001062751A1 (en) 2001-08-30
MXPA02008112A (es) 2002-11-29
IL150882A0 (en) 2003-02-12
AU3385401A (en) 2001-09-03
EP1261595A1 (en) 2002-12-04
CA2396971A1 (en) 2001-08-30
CN1404474A (zh) 2003-03-19
NO20023951D0 (no) 2002-08-20
KR20020079882A (ko) 2002-10-19
JP2003524008A (ja) 2003-08-12
US20030139419A1 (en) 2003-07-24
NO20023951L (no) 2002-08-20

Similar Documents

Publication Publication Date Title
TR200100605T2 (tr) Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı
BR0207984A (pt) Inibidores de metaloproteinase
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
PT1193270E (pt) Pirrolobenzodiazepinas
BR0108437A (pt) Piridinil-imidazóis
SE0000540D0 (sv) New compounds
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
CY1107634T1 (el) Φαρμακευτικη συνθεση
SE0004245D0 (sv) Novel compounds and their use
UY27972A1 (es) Derivados de hidantoína
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO20025590D0 (no) Fenylglycin-derivater
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BR0108500A (pt) Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase
BRPI0409276A (pt) derivados de piperazina inibidores de renina
BR0108501A (pt) Compostos de n-hidróxiformamidas substituìdos por piperidina e piperazina como agentes inibidores de metaloproteinase
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE356114T1 (de) Inhibitoren von metalloproteinasen
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0115996A (pt) Sulfamidotienopirimidinas
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
SE9903290D0 (sv) Novel compounds
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.